Filing Flows › Companies › LifeStance Health Group › Timeline
LifeStance Health Group stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+120.3% to $13.77
LifeStance Health Group (LFST) stock rose 120% over the last 252 sessions, to $13.77. On the way it reported 5 quarters, its insiders filed 14 open-market trades and 11 Form 144 notices of planned sales, and the company filed 4 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Earnings | Earnings: beat the EPS estimate by 26.7% | −5.6% (−1.1% vs SPY) | — | — |
| Oct 16, 2026 | 8-K | Directors and officers: departures, appointments, pay | +0.3% (−0.2% vs SPY) | +9.7% (+10.1% vs SPY) | — |
| Sep 11, 2026 | Insider sale | TPG GP A, LLC sold $226M | −0.2% (−1.1% vs SPY) | −3.0% (−3.7% vs SPY) | −4.6% (−7.5% vs SPY) |
| Sep 2, 2026 | Form 144 | Form 144: Vukasin Paunovich plans to sell $541K | +2.3% (+1.8% vs SPY) | +0.2% (+0.1% vs SPY) | −5.6% (−6.2% vs SPY) |
| Sep 2, 2026 | Insider sale | Paunovich Vukasin sold $541K | +2.3% (+1.8% vs SPY) | +0.2% (+0.1% vs SPY) | −5.6% (−6.2% vs SPY) |
| Aug 14, 2026 | Form 144 | Form 144: Teresa DeLuca plans to sell $95K | +1.6% (+1.8% vs SPY) | +3.4% (+5.4% vs SPY) | +9.1% (+11.3% vs SPY) |
| Aug 14, 2026 | Insider sale | DeLuca Teresa sold $95K | +1.6% (+1.8% vs SPY) | +3.4% (+5.4% vs SPY) | +9.1% (+11.3% vs SPY) |
| Aug 13, 2026 | Form 144 | Form 144: Teresa DeLuca plans to sell $250K | −0.1% (−0.8% vs SPY) | +4.8% (+5.2% vs SPY) | +5.9% (+6.9% vs SPY) |
| Aug 13, 2026 | Insider sale | DeLuca Teresa sold $250K | −0.1% (−0.8% vs SPY) | +4.8% (+5.2% vs SPY) | +5.9% (+6.9% vs SPY) |
| Aug 11, 2026 | Form 144 | Form 144: Kenneth A Burdick plans to sell $5.8M | −3.4% (−3.1% vs SPY) | +5.3% (+5.3% vs SPY) | +5.9% (+7.3% vs SPY) |
| Aug 11, 2026 | Insider sale | Burdick Kenneth A sold $5.8M | −3.4% (−3.1% vs SPY) | +5.3% (+5.3% vs SPY) | +5.9% (+7.3% vs SPY) |
| Aug 10, 2026 | Form 144 | Form 144: Summit Partners Growth Equity Fund Ix-A, L.P. plans to sell $18.5M | +9.3% (+9.4% vs SPY) | +13.6% (+13.2% vs SPY) | +16.6% (+17.6% vs SPY) |
| Aug 10, 2026 | Form 144 | Form 144: Summit Partners Growth Equity Fund Ix-B, L.P. plans to sell $11.6M | +9.3% (+9.4% vs SPY) | +13.6% (+13.2% vs SPY) | +16.6% (+17.6% vs SPY) |
| Aug 10, 2026 | Form 144 | Form 144: Summit Investors GE Ix-Vc IV, LLC plans to sell $129K | +9.3% (+9.4% vs SPY) | +13.6% (+13.2% vs SPY) | +16.6% (+17.6% vs SPY) |
| Aug 10, 2026 | Form 144 | Form 144: Vukasin Paunovich plans to sell $482K | +9.3% (+9.4% vs SPY) | +13.6% (+13.2% vs SPY) | +16.6% (+17.6% vs SPY) |
| Aug 10, 2026 | Form 144 | Form 144: Lisa K Miller plans to sell $520K | +9.3% (+9.4% vs SPY) | +13.6% (+13.2% vs SPY) | +16.6% (+17.6% vs SPY) |
| Aug 10, 2026 | Form 144 | Form 144: TPG Viii Lynnwood Holdings Aggregation, L.P. plans to sell $148M | +9.3% (+9.4% vs SPY) | +13.6% (+13.2% vs SPY) | +16.6% (+17.6% vs SPY) |
| Aug 10, 2026 | Insider sale | TPG GP A, LLC sold $145M | +9.3% (+9.4% vs SPY) | +13.6% (+13.2% vs SPY) | +16.6% (+17.6% vs SPY) |
| Aug 6, 2026 | Earnings | Earnings: beat the EPS estimate by 32.4% | +2.8% (+2.9% vs SPY) | +16.5% (+16.1% vs SPY) | +21.3% (+20.8% vs SPY) |
| Jul 7, 2026 | 8-K | Directors and officers: departures, appointments, pay | −3.8% (−3.5% vs SPY) | −1.0% (−1.6% vs SPY) | −4.9% (−7.9% vs SPY) |
| Jun 26, 2026 | Form 144 | Form 144: Robert Bessler plans to sell $9.1M | +4.0% (+4.7% vs SPY) | +13.2% (+11.8% vs SPY) | +9.7% (+9.0% vs SPY) |
| May 12, 2026 | Insider sale | TPG GP A, LLC sold $227M | +3.3% (+3.5% vs SPY) | +1.7% (+1.8% vs SPY) | +2.4% (+4.3% vs SPY) |
| May 12, 2026 | Insider sale | Shuey Eric sold $2.0M | +3.3% (+3.5% vs SPY) | +1.7% (+1.8% vs SPY) | +2.4% (+4.3% vs SPY) |
| May 12, 2026 | Insider sale | Bessler Robert sold $4.6M | +3.3% (+3.5% vs SPY) | +1.7% (+1.8% vs SPY) | +2.4% (+4.3% vs SPY) |
| May 12, 2026 | Insider sale | Black Darren M. sold $47.3M | +3.3% (+3.5% vs SPY) | +1.7% (+1.8% vs SPY) | +2.4% (+4.3% vs SPY) |
| May 7, 2026 | Earnings | Earnings: beat the EPS estimate by 10.4% | +18.4% (+18.7% vs SPY) | +9.6% (+8.4% vs SPY) | +0.7% (+0.2% vs SPY) |
| Mar 11, 2026 | 8-K | Directors and officers: departures, appointments, pay | −4.8% (−3.3% vs SPY) | −3.5% (−1.3% vs SPY) | −3.7% (−4.4% vs SPY) |
| Mar 2, 2026 | Insider sale | TPG GP A, LLC sold $145M | −1.4% (−1.4% vs SPY) | −4.4% (−2.4% vs SPY) | −14.9% (−6.9% vs SPY) |
| Mar 2, 2026 | Insider sale | Black Darren M. sold $30.2M | −1.4% (−1.4% vs SPY) | −4.4% (−2.4% vs SPY) | −14.9% (−6.9% vs SPY) |
| Feb 25, 2026 | 8-K | Directors and officers: departures, appointments, pay | −6.3% (−5.7% vs SPY) | −1.1% (+0.1% vs SPY) | −10.2% (−3.3% vs SPY) |
| Feb 25, 2026 | Earnings | Earnings: beat the EPS estimate by 64.3% | +3.7% (+2.9% vs SPY) | +1.8% (+2.8% vs SPY) | −7.1% (−2.8% vs SPY) |
| Dec 17, 2025 | Insider sale | Varanakis Ann sold $345K | +0.4% (+1.5% vs SPY) | +2.6% (+1.0% vs SPY) | +5.2% (+3.1% vs SPY) |
| Nov 21, 2025 | Insider sale | Miller Lisa K sold $368K | +4.1% (+3.1% vs SPY) | +5.0% (+0.4% vs SPY) | +13.2% (+8.0% vs SPY) |
| Nov 6, 2025 | Earnings | Earnings: missed the EPS estimate by -63.7% | +26.2% (+27.3% vs SPY) | +29.2% (+28.3% vs SPY) | +29.8% (+28.6% vs SPY) |
Insiders’ record here
In the year on the chart, LifeStance Health Group's insiders reported 0 open-market buys ($0) and 14 sales ($834M). Of the 9 old enough to score, 1 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale +20.9%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → LifeStance Health Group: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.